{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:52:33Z","timestamp":1794243153917,"version":"4.9.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T00:00:00Z","timestamp":1494460800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["(FWF) P26011 (L.K.)"],"award-info":[{"award-number":["(FWF) P26011 (L.K.)"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["FWF-P 29251-B28 (L.K.)"],"award-info":[{"award-number":["FWF-P 29251-B28 (L.K.)"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Training Network","award":["MSCA-ITN-2015-ETN ALKATRAS No 675712 (L.K.)"],"award-info":[{"award-number":["MSCA-ITN-2015-ETN ALKATRAS No 675712 (L.K.)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s11060-017-2459-z","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T11:17:01Z","timestamp":1494501421000},"page":"469-476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations"],"prefix":"10.1007","volume":"133","author":[{"given":"S.","family":"Balendran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Liebmann-Reindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Berghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Reischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Popitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. B.","family":"Geier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Birner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Streubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,11]]},"reference":[{"issue":"2","key":"2459_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/neup.12172","volume":"35","author":"H Nafisi","year":"2015","unstructured":"Nafisi H, Cesari M, Karamchandani J, Balasubramaniam G, Keith JL (2015) Metastatic ovarian carcinoma to the brain: an approach to identification and classification for neuropathologists. Neuropathology 35(2):122\u2013129. doi:\n10.1111\/neup.12172","journal-title":"Neuropathology"},{"issue":"2","key":"2459_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.20892\/j.issn.2095-3941.2016.0024","volume":"13","author":"RL Hollis","year":"2016","unstructured":"Hollis RL, Gourley C (2016) Genetic and molecular changes in ovarian cancer. Cancer Biol Med 13(2):236\u2013247. doi:\n10.20892\/j.issn.2095-3941.2016.0024","journal-title":"Cancer Biol Med"},{"issue":"Suppl 1","key":"2459_CR3","doi-asserted-by":"publisher","first-page":"i58","DOI":"10.1093\/annonc\/mdw088","volume":"27","author":"MA Bookman","year":"2016","unstructured":"Bookman MA (2016) Optimal primary therapy of ovarian cancer. Ann Oncol 27(Suppl 1):i58\u2013i62. doi:\n10.1093\/annonc\/mdw088","journal-title":"Ann Oncol"},{"issue":"10 Suppl","key":"2459_CR4","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1002\/cncr.11349","volume":"97","author":"MT Goodman","year":"2003","unstructured":"Goodman MT, Howe HL, Tung KH, Hotes J, Miller BA, Coughlin SS, Chen VW (2003) Incidence of ovarian cancer by race and ethnicity in the United States, 1992\u20131997. Cancer 97(10 Suppl):2676\u20132685. doi:\n10.1002\/cncr.11349","journal-title":"Cancer"},{"issue":"1","key":"2459_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. Cancer J Clin 64(1):9\u201329. doi:\n10.3322\/caac.21208","journal-title":"Cancer J Clin"},{"key":"2459_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12885-015-1077-4","volume":"15","author":"JY Lee","year":"2015","unstructured":"Lee JY, Yoon JK, Kim B, Kim S, Kim MA, Lim H, Bang D, Song YS (2015) Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing. BMC Cancer 15:85. doi:\n10.1186\/s12885-015-1077-4","journal-title":"BMC Cancer"},{"issue":"3","key":"2459_CR7","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E (2010) Ovarian cancer development and metastasis. Am J Pathol 177(3):1053\u20131064. doi:\n10.2353\/ajpath.2010.100105","journal-title":"Am J Pathol"},{"issue":"6","key":"2459_CR8","first-page":"746","volume":"68","author":"DM Larson","year":"1986","unstructured":"Larson DM, Copeland LJ, Moser RP, Malone JM Jr, Gershenson DM, Wharton JT (1986) Central nervous system metastases in epithelial ovarian carcinoma. Obstet Gynecol 68(6):746\u2013750","journal-title":"Obstet Gynecol"},{"issue":"7","key":"2459_CR9","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1471-0528.1981.tb01267.x","volume":"88","author":"GH Barker","year":"1981","unstructured":"Barker GH, Orledge J, Wiltshaw E (1981) Involvement of the central nervous system in patients with ovarian carcinoma. Br J Obstet Gynaecol 88(7):690\u2013694","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"2459_CR10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0090-8258(89)90515-5","volume":"33","author":"JR Hardy","year":"1989","unstructured":"Hardy JR, Harvey VJ (1989) Cerebral metastases in patients with ovarian cancer treated with chemotherapy. Gynecol Oncol 33(3):296\u2013300","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2459_CR11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ygyno.2016.09.025","volume":"143","author":"C Marchetti","year":"2016","unstructured":"Marchetti C, Ferrandina G, Cormio G, Gambino A, Cecere S, Lorusso D, De Giorgi U, Bogliolo S, Fagotti A, Mammoliti S, Narducci F, Bergamini A, Scollo P, Biglia N, Breda E, Tamberi S, Marinaccio M, Angioli R, Salerno L, Eusebi MC, Loizzi V, Scambia G, Panici PB (2016) Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19). Gynecol Oncol 143(3):532\u2013538. doi:\n10.1016\/j.ygyno.2016.09.025","journal-title":"Gynecol Oncol"},{"issue":"13","key":"2459_CR12","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.ejca.2015.06.107","volume":"51","author":"M Preusser","year":"2015","unstructured":"Preusser M, Berghoff AS, Koller R, Zielinski CC, Hainfellner JA, Liebmann-Reindl S, Popitsch N, Geier CB, Streubel B, Birner P (2015) Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma. Eur J Cancer 51(13):1803\u20131811. doi:\n10.1016\/j.ejca.2015.06.107","journal-title":"Eur J Cancer"},{"key":"2459_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1748-717x-8-36","volume":"8","author":"S Teckie","year":"2013","unstructured":"Teckie S, Makker V, Tabar V, Alektiar K, Aghajanian C, Hensley M, Beal K (2013) Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival. Radiat Oncol 8:36. doi:\n10.1186\/1748-717x-8-36","journal-title":"Radiat Oncol"},{"issue":"7353","key":"2459_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"C","year":"2011","unstructured":"Cancer Genome Atlas Research Network (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474(7353):609\u2013615. doi:\n10.1038\/nature10166","journal-title":"Nature"},{"key":"2459_CR15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1186\/1756-0500-7-805","volume":"7","author":"NS Ab Mutalib","year":"2014","unstructured":"Ab Mutalib NS, Syafruddin SE, Md Zain RR, Mohd Dali AZ, Mohd Yunos RI, Saidin S, Jamal R, Mokhtar NM (2014) Molecular characterization of serous ovarian carcinoma using a multigene next generation sequencing cancer panel approach. BMC Res Notes 7:805. doi:\n10.1186\/1756-0500-7-805","journal-title":"BMC Res Notes"},{"issue":"11","key":"2459_CR16","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1158\/2159-8290.cd-15-0369","volume":"5","author":"PK Brastianos","year":"2015","unstructured":"Brastianos PK, Carter SL, Santagata S, Cahill DP, Taylor-Weiner A, Jones RT, Van Allen EM, Lawrence MS, Horowitz PM, Cibulskis K, Ligon KL, Tabernero J, Seoane J, Martinez-Saez E, Curry WT, Dunn IF, Paek SH, Park SH, McKenna A, Chevalier A, Rosenberg M, Barker FG 2nd, Gill CM, Van Hummelen P, Thorner AR, Johnson BE, Hoang MP, Choueiri TK, Signoretti S, Sougnez C, Rabin MS, Lin NU, Winer EP, Stemmer-Rachamimov A, Meyerson M, Garraway L, Gabriel S, Lander ES, Beroukhim R, Batchelor TT, Baselga J, Louis DN, Getz G, Hahn WC (2015) Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov 5(11):1164\u20131177. doi:\n10.1158\/2159-8290.cd-15-0369","journal-title":"Cancer Discov"},{"issue":"3","key":"2459_CR17","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ygyno.2013.06.019","volume":"130","author":"JS Ross","year":"2013","unstructured":"Ross JS, Ali SM, Wang K, Palmer G, Yelensky R, Lipson D, Miller VA, Zajchowski D, Shawver LK, Stephens PJ (2013) Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies. Gynecol Oncol 130(3):554\u2013559. doi:\n10.1016\/j.ygyno.2013.06.019","journal-title":"Gynecol Oncol"},{"issue":"20","key":"2459_CR18","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1200\/jco.2016.66.6487","volume":"34","author":"EI Pentsova","year":"2016","unstructured":"Pentsova EI, Shah RH, Tang J, Boire A, You D, Briggs S, Omuro A, Lin X, Fleisher M, Grommes C, Panageas KS, Meng F, Selcuklu SD, Ogilvie S, Distefano N, Shagabayeva L, Rosenblum M, DeAngelis LM, Viale A, Mellinghoff IK, Berger MF (2016) Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid. J Clin Oncol 34(20):2404\u20132415. doi:\n10.1200\/jco.2016.66.6487","journal-title":"J Clin Oncol"},{"issue":"5","key":"2459_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.cd-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2(5):401\u2013404. doi:\n10.1158\/2159-8290.cd-12-0095","journal-title":"Cancer Discov"},{"issue":"269","key":"2459_CR20","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6(269):pl1. doi:\n10.1126\/scisignal.2004088","journal-title":"Sci Signal"},{"issue":"4","key":"2459_CR21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","volume":"54","author":"R Bender","year":"2001","unstructured":"Bender R, Lange S (2001) Adjusting for multiple testing\u2013when and how? J Clin Epidemiol 54(4):343\u2013349","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2459_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ygyno.2015.04.039","volume":"138","author":"BL Seagle","year":"2015","unstructured":"Seagle BL, Yang CP, Eng KH, Dandapani M, Odunsi-Akanji O, Goldberg GL, Odunsi K, Horwitz SB, Shahabi S (2015) TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from the Cancer Genome Atlas. Gynecol Oncol 138(1):159\u2013164. doi:\n10.1016\/j.ygyno.2015.04.039","journal-title":"Gynecol Oncol"},{"issue":"10","key":"2459_CR23","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.neo.2015.10.003","volume":"17","author":"LK Mullany","year":"2015","unstructured":"Mullany LK, Wong KK, Marciano DC, Katsonis P, King-Crane ER, Ren YA, Lichtarge O, Richards JS (2015) Specific TP53 mutants overrepresented in ovarian cancer impact CNV, TP53 activity, responses to nutlin-3a, and cell survival. Neoplasia 17(10):789\u2013803. doi:\n10.1016\/j.neo.2015.10.003","journal-title":"Neoplasia"},{"issue":"2","key":"2459_CR24","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.18632\/oncotarget.6834","volume":"7","author":"A Mafficini","year":"2016","unstructured":"Mafficini A, Simbolo M, Parisi A, Rusev B, Luchini C, Cataldo I, Piazzola E, Sperandio N, Turri G, Franchi M, Tortora G, Bovo C, Lawlor RT, Scarpa A (2016) BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing. Oncotarget 7(2):1076\u20131083. doi:\n10.18632\/oncotarget.6834","journal-title":"Oncotarget"},{"issue":"51","key":"2459_CR25","doi-asserted-by":"publisher","first-page":"21766","DOI":"10.1073\/pnas.0912499106","volume":"106","author":"AF Rubin","year":"2009","unstructured":"Rubin AF, Green P (2009) Mutation patterns in cancer genomes. Proc Natl Acad Sci USA 106(51):21766\u201321770. doi:\n10.1073\/pnas.0912499106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2459_CR26","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/annonc\/mdv164","volume":"26","author":"L Beltrame","year":"2015","unstructured":"Beltrame L, Di Marino M, Fruscio R, Calura E, Chapman B, Clivio L, Sina F, Mele C, Iatropoulos P, Grassi T, Fotia V, Romualdi C, Martini P, Noris M, Paracchini L, Craparotta I, Petrillo M, Milani R, Perego P, Ravaggi A, Zambelli A, Ronchetti E, D\u2019Incalci M, Marchini S (2015) Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study. Ann Oncol 26(7):1363\u20131371. doi:\n10.1093\/annonc\/mdv164","journal-title":"Ann Oncol"},{"issue":"9","key":"2459_CR27","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.18632\/oncotarget.1946","volume":"5","author":"JJ Wheler","year":"2014","unstructured":"Wheler JJ, Parker BA, Lee JJ, Atkins JT, Janku F, Tsimberidou AM, Zinner R, Subbiah V, Fu S, Schwab R, Moulder S, Valero V, Schwaederle M, Yelensky R, Miller VA, Stephens MP, Meric-Bernstam F, Kurzrock R (2014) Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms. Oncotarget 5(9):2349\u20132354. doi:\n10.18632\/oncotarget.1946","journal-title":"Oncotarget"},{"issue":"3","key":"2459_CR28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.yexmp.2016.04.002","volume":"100","author":"KE Muller","year":"2016","unstructured":"Muller KE, Marotti JD, de Abreu FB, Peterson JD, Miller TW, Chamberlin MD, Tsongalis GJ, Tafe LJ (2016) Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancers. Exp Mol Pathol 100(3):421\u2013425. doi:\n10.1016\/j.yexmp.2016.04.002","journal-title":"Exp Mol Pathol"},{"issue":"6","key":"2459_CR29","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/carcin\/bgq069","volume":"31","author":"PJ O\u2019Donovan","year":"2010","unstructured":"O\u2019Donovan PJ, Livingston DM (2010) BRCA1 and BRCA2: breast\/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair. Carcinogenesis 31(6):961\u2013967. doi:\n10.1093\/carcin\/bgq069","journal-title":"Carcinogenesis"},{"issue":"3","key":"2459_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1006\/gyno.2000.6085","volume":"80","author":"A Koul","year":"2001","unstructured":"Koul A, Loman N, Malander S, Borg A, Ridderheim M (2001) Two BRCA1-positive epithelial ovarian tumors with metastases to the central nervous system: a case report. Gynecol Oncol 80(3):399\u2013402. doi:\n10.1006\/gyno.2000.6085","journal-title":"Gynecol Oncol"},{"key":"2459_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2016.11.006","author":"DC Anacker","year":"2016","unstructured":"Anacker DC, Moody CA (2016) Modulation of the DNA damage response during the life cycle of human papillomaviruses. Virus Res. doi:\n10.1016\/j.virusres.2016.11.006","journal-title":"Virus Res"},{"issue":"6811","key":"2459_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/35044005","volume":"408","author":"BB Zhou","year":"2000","unstructured":"Zhou BB, Elledge SJ (2000) The DNA damage response: putting checkpoints in perspective. Nature 408(6811):433\u2013439. doi:\n10.1038\/35044005","journal-title":"Nature"},{"issue":"5","key":"2459_CR33","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.molcel.2007.11.015","volume":"28","author":"JW Harper","year":"2007","unstructured":"Harper JW, Elledge SJ (2007) The DNA damage response: ten years after. Mol Cell 28(5):739\u2013745. doi:\n10.1016\/j.molcel.2007.11.015","journal-title":"Mol Cell"},{"issue":"7035","key":"2459_CR34","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, Ashworth A (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434(7035):917\u2013921. doi:\n10.1038\/nature03445","journal-title":"Nature"},{"key":"2459_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.08.037","author":"J Mateo","year":"2016","unstructured":"Mateo J, Boysen G, Barbieri CE, Bryant HE, Castro E, Nelson PS, Olmos D, Pritchard CC, Rubin MA, de Bono JS (2016) DNA repair in prostate cancer: biology and clinical implications. Eur Urol. doi:\n10.1016\/j.eururo.2016.08.037","journal-title":"Eur Urol"},{"issue":"16","key":"2459_CR36","doi-asserted-by":"publisher","first-page":"8109","DOI":"10.1158\/0008-5472.can-06-0140","volume":"66","author":"N McCabe","year":"2006","unstructured":"McCabe N, Turner NC, Lord CJ, Kluzek K, Bialkowska A, Swift S, Giavara S, O\u2019Connor MJ, Tutt AN, Zdzienicka MZ, Smith GC, Ashworth A (2006) Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res 66(16):8109\u20138115. doi:\n10.1158\/0008-5472.can-06-0140","journal-title":"Cancer Res"},{"issue":"11","key":"2459_CR37","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/s1470-2045(16)30376-x","volume":"17","author":"JA Ledermann","year":"2016","unstructured":"Ledermann JA, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G, Scott C, Meier W, Shapira-Frommer R, Safra T, Matei D, Fielding A, Spencer S, Rowe P, Lowe E, Hodgson D, Sovak MA, Matulonis U (2016) Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial. Lancet Oncol 17(11):1579\u20131589. doi:\n10.1016\/s1470-2045(16)30376-x","journal-title":"Lancet Oncol"},{"issue":"8","key":"2459_CR38","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/annonc\/mdw142","volume":"27","author":"M Moschetta","year":"2016","unstructured":"Moschetta M, George A, Kaye SB, Banerjee S (2016) BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer. Ann Oncol 27(8):1449\u20131455. doi:\n10.1093\/annonc\/mdw142","journal-title":"Ann Oncol"},{"issue":"6","key":"2459_CR39","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/annonc\/mdw133","volume":"27","author":"UA Matulonis","year":"2016","unstructured":"Matulonis UA, Penson RT, Domchek SM, Kaufman B, Shapira-Frommer R, Audeh MW, Kaye S, Molife LR, Gelmon KA, Robertson JD, Mann H, Ho TW, Coleman RL (2016) Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1\/2 mutation: a multistudy analysis of response rates and safety. Ann Oncol 27(6):1013\u20131019. doi:\n10.1093\/annonc\/mdw133","journal-title":"Ann Oncol"},{"issue":"1","key":"2459_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/s1470-2045(14)71135-0","volume":"16","author":"AM Oza","year":"2015","unstructured":"Oza AM, Cibula D, Benzaquen AO, Poole C, Mathijssen RH, Sonke GS, Colombo N, Spacek J, Vuylsteke P, Hirte H, Mahner S, Plante M, Schmalfeldt B, Mackay H, Rowbottom J, Lowe ES, Dougherty B, Barrett JC, Friedlander M (2015) Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial. Lancet Oncol 16(1):87\u201397. doi:\n10.1016\/s1470-2045(14)71135-0","journal-title":"Lancet Oncol"},{"issue":"5","key":"2459_CR41","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrclinonc.2011.42","volume":"8","author":"MD Forster","year":"2011","unstructured":"Forster MD, Dedes KJ, Sandhu S, Frentzas S, Kristeleit R, Ashworth A, Poole CJ, Weigelt B, Kaye SB, Molife LR (2011) Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nat Rev Clin Oncol 8(5):302\u2013306. doi:\n10.1038\/nrclinonc.2011.42","journal-title":"Nat Rev Clin Oncol"},{"key":"2459_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40661-016-0024-7","volume":"3","author":"RS Meehan","year":"2016","unstructured":"Meehan RS, Chen AP (2016) New treatment option for ovarian cancer: PARP inhibitors. Gynecol Oncol Res Pract 3:3. doi:\n10.1186\/s40661-016-0024-7","journal-title":"Gynecol Oncol Res Pract"},{"key":"2459_CR43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611310","author":"MR Mirza","year":"2016","unstructured":"Mirza MR, Monk BJ, Herrstedt J, Oza AM, Mahner S, Redondo A, Fabbro M, Ledermann JA, Lorusso D, Vergote I, Ben-Baruch NE, Marth C, Madry R, Christensen RD, Berek JS, Dorum A, Tinker AV, du Bois A, Gonzalez-Martin A, Follana P, Benigno B, Rosenberg P, Gilbert L, Rimel BJ, Buscema J, Balser JP, Agarwal S, Matulonis UA (2016) Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer. N Engl J Med. doi:\n10.1056\/NEJMoa1611310","journal-title":"N Engl J Med"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-017-2459-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2459-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2459-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T05:18:35Z","timestamp":1501478315000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-017-2459-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,11]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["2459"],"URL":"https:\/\/doi.org\/10.1007\/s11060-017-2459-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,11]]}}}